Abstract
Objective
Intestinal ischemia-reperfusion (IIR)-induced gut injury remains a challenge for critically ill patients despite the oxidative stress theory that has been elaborated. This study aimed to test whether Toll-like receptor 4 (TLR4) is involved in gut injury during IIR and whether somatostatin (SST) affects TLR4-nuclear factor-κB (NF-κB) cytokine pathway in the intestinal mucosa of macaques.
Design
Fifteen macaques were randomized into control, IIR, and SST + IIR groups. Pieces of isolated ileal epithelium from each animal were incubated with lipopolysaccharide (LPS), interferon-γ, or SST. Expression of TLR4 and NF-κBp65 was evaluated by immunohistochemical staining, Western blot analysis and reverse transcription polymerase chain reaction. Cytokine levels were measured by ELISA. Radioimmunoassay was used to determine of SST levels.
Measurements and Main Results
Significant overexpression (IIR vs control) of ileal TLR4 (0.17 ± 0.03 vs 0.05 ± 0.02), NF-κBp65 (0.55 ± 0.11 vs 0.15 ± 0.05), and TNF-α (213.2 ± 29.2 vs 56.0 ± 10.04) after IIR was greatly decreased (p < 0.05) by prophylactic use of SST (TLR4: 0.06 ± 0.02; NF-κBp65: 0.26 ± 0.09; TNF-α: 97.1 ± 32.3) in vivo. TLR4 expression in the ileal epithelium treated with LPS and SST (1,330 ± 93) was significantly lower than that in the ileal epithelium treated with LPS alone (2,088 ± 126) in vitro. SST levels in plasma (3.67 ± 0.41 ng/ml) and ileal mucosa (1,402.3 ± 160 ng/mg protein) of the IIR group were significantly lower than those (6.09 ± 1.29 ng/ml, 2,234. 8 ± 301.8 ng/mg protein) in the control group (p < 0.05).
Conclusions
Endogenous SST is a crucial inhibitor of massive inflammatory injury in the intestinal mucosa via direct suppression of the TLR4-NF-κB cytokine pathway induced by LPS in ileal epithelium. IIR attacks caused shortages of endogenous SST in the plasma and intestinal mucosa of macaques in this study. Therefore, preventive supplements of SST may limit intestinal injury of macaques by IIR.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Stechmiller JK, Treloar D, Allen N. Gut dysfunction in critically ill patients: a review of the literature. Am J Crit Care 1997;6:204–209.
McNeill JR, Stark RD, Greenway CV. Intestinal vasoconstriction after haemorrhage: role of vasopressin and angiotensin. Am J Physiol 1970;219:1342–1347.
Magnotti LJ, Deitch EA. Burns, bacterial translocation, gut barrier function, and failure. J Burn Care Rehabil 2005;26:383–391.
Deitch EA, Xu D, Kaise VL. Role of the gut in the development of injury- and shock induced SIRS and MODS: the gut-lymph hypothesis, a review. Front Biosci 2006;11:520–528.
Thoma-Uszynski S, Stenger S, Takeuchi O. Induction of direct antimicrobial activity through mammalian Toll-like receptor. Science 2001;291:1544–1547.
Medzhitov R, Preston-Hulburt P, Janeway CA Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997;388:394–397.
Faure E, Thomas L, Xu H. Bacterial lipopolysaccharide and IFN gamma induce Toll like receptor 2 and Toll like receptor 4 expression in human endothelial cells: role of NF-kappa B activation. J Immunol 2001;166:2018–2024.
Pearl-Yafe M, Fabian I, Halperin D, et al. Interferon-gamma and bacterial lipopolysaccharide act synergistically on human neutrophils enhancing interleukin-8, interleukin-1beta, tumor necrosis factor-alpha, and interleukin-12 p70 secretion and phagocytosis via upregulation of toll-like receptor 4. Shock 2007;27:226–231.
Abreu MT, Arnold ET, Thomas LS, et al. TLR4 and MD-2 expression is regulated by immune-mediated signal in human intestinal epithelial cells. J Biol Chem 2002;277:20431–20437.
Chowers Y, Cahalon L, Lahav M, et al. Somatostatin through its specific receptor inhibits spontaneous and TNF-alpha and bacteria-induced IL-8 and IL-1 beta secretion from intestinal epithelial cells. J Immunol 2000;165:2955–2961.
Than M, Nemeth J, Szilvassy Z, et al. Systemic anti-inflammatory effect of somatostatin released from capsaicin-sensitive vagal and sciatic sensory fibers of the rat and guinea-pig. Eur J Pharmacol 2000;399:251–258.
Tang C, Lan C, Liu R. Alleviation of multiple organ dysfunction syndrome by somatostatin via suppression of intestinal mucosal mast cells. Shock 2005;23:470–475.
Hacioglu A, Algin C, Pasaoglu O, et al. Protective effect of leptin against ischemia-reperfusion injury in the rat small intestine. BMC Gastroenterol 2005;5:37.
Poon RT, Yeung C, Lo CM, et al. Prophylactic effect of somatostatin on post-ERCP pancreatitis: a randomized controlled trial. Gastrointest Endosc 1999;49:593–598.
Rogler G, Daig R, Aschenbrenner E, et al. Establishment of long-term primary cultures of human small and large intestinal epithelial cells. Lab Invest 1998;78:889–890.
Perreault N, Beaulieu JF. Primary cultures of fully differentiated and pure human intestinal epithelial cells. Exp Cell Res 1998;245:34–42.
Kaiser GC, Yan F, Polk DB. Mesalamine blocks tumor necrosis factor growth inhibition and nuclear factor kB activation in mouse coloncytes. Gastroenterology 1999;116:602–609.
Ozturk H, Duran H, Uzunlar AK. Mibefradil, a T-type Ca2+ channel blocker, protects against mesenteric ischemia-reperfusion-induced oxidative injury and histologic alterations in intestinal mucosa in rats. Dig Dis Sci 2006;51:1454–1460.
Green BT, Tendler DA. Ischemic colitis: a clinical review. South Med J 2005;98:217–222.
Shimazu R, Akashi S, Ogata H, et al. MD-2,a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor-4. J Exp Med 1999;189:1777–1782.
Yang H, Young DW, Gusovsky F, et al. Cellular events mediated by lipopolysaccharide stimulated toll-like receptor 4. MD2 is required for activation of mitogen-activated protein kinases and Elk-1. J Biol Chem 2000;275:20861–20866.
Nagai Y, Akashi S, Nagafuku, M, et al. Essential role of MD2 in LPS responsiveness and TLR4 distribution. Nat Immunol 2002;3:667–672.
Konno K, Wakabayashi Y, Akashi-, Takamura S, et al. A molecule that is associated with Toll-like receptor 4 and regulates its cell surface expression. Biochem Biophys Res Commun 2006;339:1076–1082.
Feng CG, Scanga, CA, Collazo-Custodio CM, et al. Mice lacking myeloid differentiation factor 88 display profound defects in host resistance and immune responses to Mycobacterium avium infection not exhibited by Toll-like receptor 2 (TLR2)- and TLR4-deficient animals. J Immunol 2003;171:4758–4764.
Hoebe K, Du X, Georgel P, et al. Identification of LPS as a key transducer of MyD88-independent TIR ignaling. Natur 2003;424:743–748.
Abraham E. NF-κB activation. Crit Care Med 2000;28(Suppl):100–104.
Nichols TC. NF-kappaB and reperfusion injury. Drug News Perspect 2004;17:99–104.
Acknowledgment
This work was performed at the Laboratory of Peptides Related to Human Diseases, West China Hospital, Sichuan University and was supported by the technicians in that laboratory.
Author information
Authors and Affiliations
Corresponding author
Additional information
Grant support: This study is supported by Key Grant #30330270 of Natural Science Fund of China.
Rights and permissions
About this article
Cite this article
Wu, H., Liu, L., Tan, Q. et al. Somatostatin Limits Intestinal Ischemia-Reperfusion Injury in Macaques via Suppression of TLR4-NF-κB Cytokine Pathway. J Gastrointest Surg 13, 983–993 (2009). https://doi.org/10.1007/s11605-009-0816-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-009-0816-8